SPARC and central nervous system cancer: Since 1999, SPARC has been consistently reported to be overexpressed in various types of tumors, such as breast cancer, liver cancer, neuroblastoma, and glioma (Le Bail et al., 1999; Gorantla et al., 2013; Lin et al., 2016; Gao et al., 2021).